[{"indications": "Indications\u00a0see under Dose", "name": "PANTOPRAZOLE", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "1 Gastro-intestinal system", "1.3 Antisecretory drugs and mucosal protectants", "1.3.5 Proton pump inhibitors"], "cautions": "Cautions\u00a0\n(From 1.3.5 Proton pump inhibitors: British National Formulary)\nCautions\u00a0Proton pump inhibitors may mask the symptoms of gastric cancer; particular care is required in those presenting with \u2018alarm features\u2019 (see Dyspepsia), in such cases gastric malignancy should be ruled out before treatment. A proton pump inhibitor should be prescribed for appropriate indications at the lowest effective dose for the shortest period; the need for long-term treatment should be reviewed periodically.; interactions: Appendix 1 (proton pump inhibitors)", "side-effects": "Side-effects\u00a0\n(From 1.3.5 Proton pump inhibitors: British National Formulary)\nSide-effects\u00a0Side-effects of the proton pump inhibitors include gastro-intestinal disturbances (including nausea, vomiting, abdominal pain, flatulence, diarrhoea, constipation), and headache. Less frequent side-effects include dry mouth, peripheral oedema, dizziness, sleep disturbances, fatigue, paraesthesia, arthralgia, myalgia, rash, and pruritus. Other side-effects reported rarely or very rarely include taste disturbance, stomatitis, hepatitis, jaundice, hypersensitivity reactions (including anaphylaxis, bronchospasm), fever, depression, hallucinations, confusion, gynaecomastia, interstitial nephritis, hyponatraemia, hypomagnesaemia (with long-term treatment), blood disorders (including leucopenia, leucocytosis, pancytopenia, thrombocytopenia), visual disturbances, sweating, photosensitivity, alopecia, Stevens-Johnson syndrome, and toxic epidermal necrolysis. By decreasing gastric acidity, proton pump inhibitors may increase the risk of gastro-intestinal infections (including Clostridium difficile infection).Rebound acid hypersecretion and protracted dyspepsia may occur after stopping prolonged treatment with a proton pump inhibitor.; also hyperlipidaemia, weight changes", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/56356.htm", "doses": ["By mouth, benign gastric ulcer, adult over 18 years, 40\u00a0mg daily for 8 weeks; in\r\nsevere cases increase up to 80\u00a0mg daily", "Duodenal ulcer, adult over 18\r\nyears, 40\u00a0mg daily for 4 weeks; in severe cases increase up to 80\u00a0mg\r\ndaily", "Duodenal or benign gastric ulcer associated with Helicobacter\r\npylori, see Recommended Regimens for Helicobacter pylori Eradication", "Prophylaxis of NSAID-associated gastric or duodenal ulcer in\r\npatients with an increased risk of gastroduodenal complications who\r\nrequire continued NSAID treatment, adult over 18 years, 20\u00a0mg daily", "Gastro-oesophageal reflux disease, adult and child over 12 years, 20\u201380\u00a0mg\r\ndaily in the morning for 4 weeks, continued for further 4 weeks if\r\nnot fully healed; maintenance 20\u00a0mg daily, increased to 40\u00a0mg daily\r\nif symptoms return", "Zollinger\u2013Ellison syndrome (and other hypersecretory conditions), adult over 18 years, initially 80\u00a0mg once daily adjusted\r\naccording to response (elderly max.\r\n40\u00a0mg daily); daily doses above 80\u00a0mg given in 2 divided doses", "By intravenous injection over at\r\nleast 2 minutes or by intravenous infusion, adult over 18 years, duodenal ulcer,\r\ngastric ulcer, and gastro-oesophageal reflux, 40\u00a0mg daily until oral\r\nadministration can be resumed", "Zollinger\u2013Ellison syndrome (and other hypersecretory conditions), adult over 18 years, initially 80\u00a0mg (160\u00a0mg if rapid\r\nacid control required) then 80\u00a0mg once daily adjusted according to\r\nresponse; daily doses above 80\u00a0mg given in 2 divided doses"], "pregnancy": "Pregnancy\u00a0manufacturer advises avoid unless potential benefit\r\noutweighs risk\u2014fetotoxic in animals"}]